Asana Medical, Inc.,, an emerging life science company focused on the development and commercialization of its innovative tissue engineered therapy to treat Inflammatory Bowel Disease ("IBD"), is pleased to announce that Dr. Hal Wrigley has joined the Company's Board of Directors.
Dr. Wrigley, a dentist by trade and entrepreneur, graduated from The University of Pittsburgh, where he earned a Bachelor's Degree majoring in Chemistry and Biochemistry, as well as his Doctor of Dental Medicine degree. He completed a residency in Anesthesiology in 1968. After his studies at the University of Pittsburgh, he served as a U.S. Army Captain in the Vietnam War from 1969-1971, and as a member of the Green Berets, received two Bronze Stars and the Air Medal. Following his military service, he led a successful dental practice for 15 years.
In 1988, Dr. Wrigley founded Applied Concepts, Inc., where he designed and developed the RoboGrip™ pliers for Craftsman Tools, a division of Sears, Roebuck & Co. RoboGrip™ became the best-selling hand tool in the history of Sears and received the Top 20 Tools Award from "Motor Trend" magazine in 1993. He continued to serve as President and CEO of Applied Concepts until it became a Division of Emerson Electric Co. in 1994. Dr. Wrigley served as Division President until retiring from that position in 2004. From 2006-2009, Dr. Wrigley served as President of Knightsbridge Biofuels (formerly Knightsbridge Petroleum).
Dr. Wrigley has served as an advisor to three University boards; University of Pittsburgh School of Bioengineering, School of Dental Medicine and Penn State University School Information Science and Technology. Presently, Dr. Wrigley serves on the Board of Advisors for McGowan Institute of Regenerative Medicine. Dr. Wrigley has received numerous awards throughout his professional career including the Emerson Shareholder Value Award, Emerson Top Division President Evaluation from Employee's Award, The Sears Quality Award, Popular Science Magazine's Top Tool Award, and Top Marketing Infomercial Award. He also holds three U.S patents awarded in the U.S.
"We welcome and are honored to have Dr. Wrigley join the Asana Board of Directors. His diverse experience, robust leadership, and commitment to excellence further fortifies our already strong Board," stated Dr. Christine V. Sapan, CEO of Asana Medical, Inc.
"I am thrilled and passionate about being able to help Asana develop and commercialize a technology that will treat patients with such debilitating diseases as Ulcerative Colitis and Crohn's Disease. I am very excited about the opportunity to work closely with Dr. Sapan and Asana's team of executives in this very important endeavor" stated Dr. Wrigley.
ABOUT ASANA MEDICAL, INC.
Asana Medical, Inc. is an emerging life science company developing tissue engineered therapies for the treatment of Inflammatory Bowel Disease (IBD) and other GI diseases. The Company's lead therapy, a novel application of a proven technology, will be a first-in-class therapy for patients suffering from Ulcerative Colitis. This therapy will be positioned to compete in a multi-billion dollar market dominated by biologic and drug therapies that can have significant side effects. Additionally, 20-30% of patients do not benefit from these therapies and have no alternative except colon removal surgery. Asana has an experienced management team, strong patent protection, world-class advisors in business and medicine, and compelling preclinical proof-of-concept data. For more information, visit www.asanamedical.com.